We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Unexpected Binding Between SARS-CoV-2 and Antiviral Drug

News   Mar 24, 2021 | Original story from Oak Ridge National Laboratory

 
Unexpected Binding Between SARS-CoV-2 and Antiviral Drug

Neutron scattering experiments show electric charges, shown in red, blue and gray, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy

 
 
Advertisement
 

RELATED ARTICLES

CRISPRoff: A New Addition to the CRISPR Toolbox

News

Researchers have described a new gene-editing technology called CRISPRoff that allows researchers to control gene expression with high specificity while leaving the sequence of the DNA unchanged. The method is stable enough to be inherited through hundreds of cell divisions, and is also fully reversible.

READ MORE

Urgent Need To Address Air Quality Highlighted by COVID-19

News

Studies on pollution, respiratory and health disparities have been reviewed and ambient air pollution has been shown to worsen viral respiratory infections. Now, a similar association between ambient air pollution and worse COVID-19 outcomes has been shown.

READ MORE

IL-33 Implicated in SARS-CoV-2 Immunity

News

Researchers have unveiled a novel feature of COVID-19 immunity, which could have implications for future therapies. The study points to the involvement of Interleukin 33 when immune cells encounter Sars-CoV-2 for a second time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE